Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies

E Eleanor C. Williams L Lovisa Franzén M Martina Olsson Lindvall G Gregory Hamm (Integrated BioAnalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca) S Steven Oag M Muntasir Mamun Majumder J James Denholm A Azam Hamidinekoo J Javier Escudero Morlanes M Marco Vicari J Joakim Lundeberg L Laura Setyo T Trevor M. Godfrey L Livia S. Eberlin A Aleksandr Zakirov (Department of Clinical Neurosciences, University of Cambridge) J Jorrit J. Hornberg M Marianna Stamou P Patrik L. Ståhl A Anna Ollerstam J Jennifer Y. Tan I Irina Mohorianu

Abstract

Abstract Recent developments in spatially resolved -omics have enabled the joint study of gene expression, metabolite levels and tissue morphology, offering greater insights into biological pathways. Integrating these modalities from matched tissue sections to probe spatially-coordinated processes, however, remains challenging. Here we introduce MAGPIE, a framework for co-registering spatially resolved transcriptomics, metabolomics, and tissue morphology from the same or consecutive sections. We show MAGPIE’s generalisability and scalability on spatial multi-omics data from multiple tissues, combining Visium with MALDI and DESI mass spectrometry imaging. MAGPIE was also applied to new multi-modal datasets generated with a specialised sampling strategy to characterise the metabolic and transcriptomic landscape in an in vivo model of drug-induced pulmonary fibrosis and to link small-molecule co-detection with endogenous lung responses. MAGPIE demonstrates the refined resolution and enhanced interpretability that spatial multi-modal analyses provide for studying tissue injury especially in pharmacological contexts, and delivers a modular, accessible workflow for data integration.

Article Details

Volume / Issue Vol. 17, Issue 1
Published January 07, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (21)

E

Eleanor C. Williams

L

Lovisa Franzén

M

Martina Olsson Lindvall

G

Gregory Hamm

Integrated BioAnalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca

S

Steven Oag

M

Muntasir Mamun Majumder

J

James Denholm

A

Azam Hamidinekoo

J

Javier Escudero Morlanes

M

Marco Vicari

J

Joakim Lundeberg

L

Laura Setyo

T

Trevor M. Godfrey

L

Livia S. Eberlin

A

Aleksandr Zakirov

Department of Clinical Neurosciences, University of Cambridge

J

Jorrit J. Hornberg

M

Marianna Stamou

P

Patrik L. Ståhl

A

Anna Ollerstam

J

Jennifer Y. Tan

I

Irina Mohorianu